Publication

Klebba JE, Buster DW, Nguyen AL, Swatkoski S, Gucek M, Rusan NM, Rogers GC. 2013. Polo-like kinase 4 autodestructs by generating its Slimb-binding phosphodegron. Curr Biol. 23:2255–2261. doi:10.1016/j.cub.2013.09.019.

Tula-Sanchez AA, Havas AP, Alonge PJ, Klein ME, Doctor SR, Pinkston W, Glinsmann-Gibson BJ, Rimsza LM, Smith CL. 2013. A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma: Role of cyclin-dependent kinase inhibitors. Cancer Biol Ther. 14:949–61. doi:10.4161/cbt.25941.

Kadiyala V, Patrick NM, Mathieu W, Jaime-Frias R, Pookhao N, An L, Smith CL. 2013. Class I lysine deacetylases facilitate glucocorticoid-induced transcription. J Biol Chem. 288:28900–12. doi:10.1074/jbc.M113.505115.

Sugeng AJ, Beamer PI, Lutz EA, Rosales CB. 2013. Hazard-ranking of agricultural pesticides for chronic health effects in Yuma County, Arizona. Sci Total Environ. 463-464:35–41. doi:10.1016/j.scitotenv.2013.05.051.

Jiralerspong S, Kim ES, Dong W, Feng L, Hortobagyi GN, Giordano SH. 2013. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol. 24:2506–14. doi:10.1093/annonc/mdt224.

Bean MG, Stone J, Moskowitz GB, Badger TA, Focella ES. 2013. Evidence of nonconscious stereotyping of Hispanic patients by nursing and medical students. Nurs Res. 62:362–7. doi:10.1097/NNR.0b013e31829e02ec.

Harris DT. 2013. Umbilical cord tissue mesenchymal stem cells: characterization and clinical applications. Curr Stem Cell Res Ther. 8:394–9. doi:10.2174/1574888x11308050006.

Bell ML, McKenzie JE. 2013. Designing psycho-oncology randomised trials and cluster randomised trials: variance components and intra-cluster correlation of commonly used psychosocial measures. Psychooncology. 22:1738–47. doi:10.1002/pon.3205.

Nagle RB, Algotar AM, Cortez CC, Smith K, Jones C, Sathyanarayana UG, Yun S, Riley J, Nagy D, Dittamore R, et al. 2013. ERG overexpression and PTEN status predict capsular penetration in prostate carcinoma. Prostate. 73:1233–40. doi:10.1002/pros.22675.

Bowen C, Ju J-H, Lee J-H, Paull TT, Gelmann EP. 2013. Functional activation of ATM by the prostate cancer suppressor NKX3.1. Cell Rep. 4:516–29. doi:10.1016/j.celrep.2013.06.039.

Cooley JH, Quale LM. 2013. Skin cancer preventive behavior and sun protection recommendations. Semin Oncol Nurs. 29:223–6. doi:10.1016/j.soncn.2013.06.008.

Belzer M, Morales M, Jagadish B, Mash EA, Wright SH. 2013. Substrate-dependent ligand inhibition of the human organic cation transporter OCT2. J Pharmacol Exp Ther. 346:300–10. doi:10.1124/jpet.113.203257.

Meenach SA, Anderson KW, Hilt JZ, McGarry RC, Mansour HM. 2013. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer. Eur J Pharm Sci. 49:699–711. doi:10.1016/j.ejps.2013.05.012.

Cen B, Mahajan S, Wang W, Kraft AS. 2013. Elevation of receptor tyrosine kinases by small molecule AKT inhibitors in prostate cancer is mediated by Pim-1. Cancer Res. 73:3402–11. doi:10.1158/0008-5472.CAN-12-4619.

Zhang J, Chen QM. 2013. Far upstream element binding protein 1: a commander of transcription, translation and beyond. Oncogene. 32:2907–16. doi:10.1038/onc.2012.350.

Miller JA, Lang JE, Ley M, Nagle R, Hsu C-H, Thompson PA, Cordova C, Waer A, Chow H-HS. 2013. Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer. Cancer Prev Res (Phila). 6:577–84. doi:10.1158/1940-6207.CAPR-12-0452.

Woo H-H, Baker T, Laszlo C, Chambers SK. 2013. Nucleolin mediates microRNA-directed CSF-1 mRNA deadenylation but increases translation of CSF-1 mRNA. Mol Cell Proteomics. 12:1661–77. doi:10.1074/mcp.M112.025288.

Torres MA, Pace TW, Liu T, Felger JC, Mister D, Doho GH, Kohn JN, Barsevick AM, Long Q, Miller AH. 2013. Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa B. Cancer. 119:1951–9. doi:10.1002/cncr.28003.

Escalante AM, McGrath RT, Karolak MR, Dorr RT, Lynch RM, Landowski TH. 2013. Preventing the autophagic survival response by inhibition of calpain enhances the cytotoxic activity of bortezomib in vitro and in vivo. Cancer Chemother Pharmacol. 71:1567–76. doi:10.1007/s00280-013-2156-3.

Berglund E, Berglund D, Akcakaya P, Ghaderi M, Daré E, Berggren P-O, Köhler M, Aspinwall CA, Lui W-O, Zedenius J, et al. 2013. Evidence for Ca(2+)-regulated ATP release in gastrointestinal stromal tumors. Exp Cell Res. 319:1229–38. doi:10.1016/j.yexcr.2013.03.001.

Lencinas A, Chhun DC, Dan KP, Ross KD, Hoover EA, Antin PB, Runyan RB. 2013. Olfactomedin-1 activity identifies a cell invasion checkpoint during epithelial-mesenchymal transition in the chick embryonic heart. Dis Model Mech. 6:632–42. doi:10.1242/dmm.010595.

Badger TA, Segrin C, Hepworth JT, Pasvogel A, Weihs K, López AM. 2013. Telephone-delivered health education and interpersonal counseling improve quality of life for Latinas with breast cancer and their supportive partners. Psychooncology. 22:1035–42. doi:10.1002/pon.3101.

Wright LE, Frye JB, Lukefahr AL, Timmermann BN, Mohammad KS, Guise TA, Funk JL. 2013. Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis. J Nat Prod. 76:316–21. doi:10.1021/np300663v.

Cance WG, Kurenova E, Marlowe T, Golubovskaya V. 2013. Disrupting the scaffold to improve focal adhesion kinase-targeted cancer therapeutics. Sci Signal. 6:pe10. doi:10.1126/scisignal.2004021.

Bernstein C, Nfonsam V, Prasad AR, Bernstein H. 2013. Epigenetic field defects in progression to cancer. World J Gastrointest Oncol. 5:43–9. doi:10.4251/wjgo.v5.i3.43.